KY-B602

N/A

Report date: 2022/04/18 14:53:27

Base Information

Drug NameKY-B602
Drug Alias NameKY-B-602KY-B602
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionAnti-Tumor necrosis factor receptor superfamily member 4
TargetsTumor necrosis factor receptor superfamily member 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesKYinno Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKYinno Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A